# Shanghai BravoBio Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-bravobio-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.bravobio.com
- Latest round: Series A (Dec 20, 2021)
- Investors on record: 5

## About

Based in Shanghai, China and founded in 2011, Shanghai BravoBio Co., Ltd. operates as a vaccine developer and manufacturer focusing on providing vaccine products. The company's president and founder has 23 years of experiences in biopharmaceuticals industry and had developed 7 products which were approved by SFDA and marketed in China. He was executive president of Shanghai Zerun Biotechnology Co., Ltd., in charge of management of QA/QC, manufacture, engineering and maintenance, regulatory affairs, marketing and sales.

The company's business include human vaccines, animal vaccines, therapeutic peptides and proteins, diagnostics and other biological technology.

## Funding rounds

- Series A, Dec 20, 2021 — Tronfund, Chengda Biotechnology, GF Venture Capital, Shenzhen Qianhai Beizeng Asset Management, Yatai Group

## Investors

- Tronfund (https://capitalatlas.ai/funds/tronfund) — Series A
- Chengda Biotechnology — Series A
- GF Venture Capital (https://capitalatlas.ai/funds/gf-venture-capital) — Series A
- Shenzhen Qianhai Beizeng Asset Management (https://capitalatlas.ai/funds/shenzhen-qianhai-beizeng-asset-management) — Series A
- Yatai Group — Series A